Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus.
Leandro Cardarelli-LeiteJohn ChungDarren KlassVladimir MarquezFrank ChouStephen HoHenry WaltonHoward LimPeter Tae Wan KimAnastasia HadjivassiliouDavid M LiuPublished in: Cardiovascular and interventional radiology (2020)
In patients with advanced hepatocellular carcinoma and portal vein tumor thrombus, A-TARE is associated with longer survival than cTARE. Neither modality is associated with deleterious effects on liver function.
Keyphrases